Showing results (41-50 of 4,490) with videos related to
Sort By:
Pageof 449
Advances in Therapy|February 4, 2021
Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled StudiesDan J Stein, Jon-Paul Khoo, Françoise Picarel-Blanchot, et al.Advances in Therapy|January 3, 2022
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO StudyKurt de Vlam, Adrien Nzeusseu Toukap, Marie-Joëlle Kaiser, et al.Advances in Therapy|December 7, 2021
Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild AsthmaPeter Daley-Yates, Bhumika Aggarwal, Zrinka Lulic, et al.Advances in Therapy|December 11, 2021
Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to KnowLois E Krahn, Phyllis C Zee, Michael J ThorpyAdvances in Therapy|March 18, 2008
A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: are they an appropriate tool for drug screening?Didem Dayangaç-Erden, Haluk Topaloğlu, Hayat Erdem-YurterAdvances in Therapy|March 22, 2021
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 TrialYuqin Song, Hui Zhou, Huilai Zhang, et al.Advances in Therapy|March 23, 2021
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's DiseaseLaurent Peyrin-Biroulet, Edouard Louis, Edward V Loftus, et al.Advances in Therapy|June 18, 2011
Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitisShachar Tauber, Gale Cupp, Richard Garber, et al.Advances in Therapy|June 21, 2011
Adverse effects of azacitidine: onset, duration, and treatmentAntonio Martínez-FrancésAdvances in Therapy|June 21, 2011
Azacitidine adverse effects in patients with myelodysplastic syndromesL San Miguel Amigo, R Franco Osorio, S Mercadal Vilchez, et al.Pageof 449